Our clinic is providing the CA 27.29 antigen test for our patients with stage II and stage III breast cancer. How should this service be coded? ...
Subscribe or sign in to view the full article.
Article Overview
This short coding article addresses a laboratory test used in the follow-up care of certain breast cancer patients and explains how the service is identified in CPT. It is written for coders, billers, and clinical staff who need to match a tumor marker test to the correct medical code set while understanding the general clinical context and the reason the test is being discussed.
Why This Topic Matters
Accurate reporting of laboratory tumor marker testing depends on recognizing the correct CPT identifier and understanding the type of service being performed. This matters for claim accuracy, documentation review, and alignment between the ordered test and the billed service.
What You Will Learn
- What type of laboratory test the article is discussing
- Which code set the article uses for the service
- How the article frames the clinical context for the test
- Why the test is relevant in breast cancer follow-up care
Who Should Read This
- Medical coders
- Billing staff
- Clinical documentation staff
- Oncology practice administrators
- Laboratory billing personnel
Codes Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com